Cincinnati Children's Hospital Medical Center, University of Cincinnati-College of Medicine, United States of America.
Cincinnati Children's Hospital Medical Center, University of Cincinnati-College of Medicine, United States of America.
Epilepsy Behav. 2019 Oct;99:106463. doi: 10.1016/j.yebeh.2019.106463. Epub 2019 Aug 30.
The purpose of the present study was to establish clinical cutoffs for the PedsQL Epilepsy Module scales by dichotomizing scores into normative or impaired. We predicted that these cutoffs would be useful in identifying children at greater risk for impairments in health-related quality of life (HRQOL) including those who exhibit effects of ongoing seizures, antiepileptic drugs (AEDs), and polytherapy.
Two hundred and thirty-seven youth (2-18 years old) and their caregivers were recruited from five tertiary care hospitals across the United States. Caregivers and youth (5 years and older) completed the parent- or self-report versions of the PedsQL Epilepsy Module. Caregivers also completed measures of behavior and mood, AED side effects, and executive functioning in children. Clinical cutoffs were calculated in two ways: anchor-based (receiver operating characteristic (ROC) curve) and distribution-based (0.5 standard deviation (SD)). Medical characteristics were abstracted from the medical chart. t-Tests and chi-square tests were used to determine whether children's HRQOL classified as normative or impaired in epilepsy quality of life differed on seizure freedom, AED side effects, and polytherapy.
The final clinical cutoffs were as follows for each PedsQL Epilepsy Module subscale (caregiver and child): Impact (Parent = 60.7; Child = 64.39), Cognitive (Parent = 38.11; Child = 50.97), Executive Functioning (Parent = 46.65; Child = 57.15), Sleep (Parent = 42.07; Child = 43.90), and Mood/Behavior (Parent = 54.14; Child = 53.30). Youth with more severe AED side effects, ongoing seizures, and/or on polytherapy were more likely to have impaired quality of life across domains.
Clinical cutoffs extend this instrument's utility in surveilling common psychosocial comorbidities, tracking changes in functioning over time, and informing clinical decision-making in youth with epilepsy including recommendations for additional assessment and intervention by a range of health providers serving youth with epilepsy (YWE).
本研究旨在通过将分数分为正常或受损,为 PedsQL 癫痫模块量表建立临床临界值。我们预测,这些临界值将有助于识别健康相关生活质量(HRQOL)受损风险较高的儿童,包括那些表现出持续发作、抗癫痫药物(AEDs)和多药治疗影响的儿童。
从美国五家三级保健医院招募了 237 名儿童(2-18 岁)及其照顾者。照顾者和儿童(5 岁及以上)完成了父母或自我报告的 PedsQL 癫痫模块。照顾者还完成了儿童行为和情绪、AED 副作用和执行功能的测量。临床临界值通过两种方式计算:基于锚(接收者操作特征(ROC)曲线)和基于分布(0.5 标准差(SD))。从病历中提取医疗特征。t 检验和卡方检验用于确定癫痫生活质量正常或受损的儿童在无发作、AED 副作用和多药治疗方面是否存在差异。
最终的 PedsQL 癫痫模块各分量表的临床临界值如下(照顾者和儿童):影响(家长=60.7;儿童=64.39)、认知(家长=38.11;儿童=50.97)、执行功能(家长=46.65;儿童=57.15)、睡眠(家长=42.07;儿童=43.90)和情绪/行为(家长=54.14;儿童=53.30)。AED 副作用更严重、持续发作和/或多药治疗的儿童更有可能在各领域出现生活质量受损。
临床临界值扩展了该工具在监测常见心理社会合并症、随时间跟踪功能变化以及为癫痫儿童提供临床决策的效用,包括建议由为癫痫儿童提供服务的一系列健康提供者(YWE)进行进一步评估和干预。